Daniel Razansky is a Full Professor at the Department of Information Technology and Electrical Engineering, ETH Zurich, leading the Professorship for Biomedical Imaging. His research spans engineering, physics, biology, and medicine, focusing on developing advanced in vivo imaging tools like optoacoustic tomography and ultrasound neuromodulation. His recent work emphasizes multi-scale functional and molecular imaging , with applications in neuroscience , Alzheimer’s disease , and stroke diagnostics . Collaborations include National Tsing Hua University and the EU Horizon consortium SWEEPICS. Current projects target hybrid imaging systems (e.g., MRI-MSOT) and image-guided neuromodulation. Scientific awards include the IPPA James Smith Prize for his contributions. His lab has secured significant grants, including a $2.5M NIH award and SNSF funding. He mentors PhD students like Quanyu Zhou and Eva Remlova, who have received accolades for their research. The Razansky Lab at ETH Zurich’s Preclinical Imaging Center explores medical microrobotics , dynamic fluid flow imaging , and neuroimaging techniques , aiming to bridge engineering with clinical applications.
Oliver Schmitz is a Professor in the Department of Nuclear Engineering & Engineering Physics at the University of Wisconsin-Madison, where he leads research in plasma edge physics for magnetic confinement fusion and next-generation particle accelerators. His work bridges experimental plasma science, computational modeling, and diagnostic development with applications in both tokamaks and stellarators. Education: PhD (2006), Heinrich-Heine-Universität Diploma (2003), Rheinische Friedrich-Wilhelms-Universität Professor Schmitz's research focuses on 3D plasma edge transport phenomena, plasma-wall interactions, and helicon plasma generation for wakefield accelerators. His group employs advanced computational tools like EMC3-EIRENE for 3D plasma edge modeling and develops active spectroscopic diagnostics to measure plasma parameters through atomic emission analysis. Key themes include resonant magnetic perturbation effects in tokamaks, inherent 3D physics in stellarators, and high-density plasma sustainment for accelerator applications. He actively develops atomic models to interpret spectroscopic data and operates helicon plasma test stands for fundamental process studies. Recent publications reveal strong emphasis on experimental-computational integration for fusion boundary physics, with significant contributions to ITER divertor solutions, stellarator exhaust optimization, and plasma-facing materials. The work shows growing focus on wakefield accelerator diagnostics through helicon plasma sources and advanced spectroscopy, alongside persistent innovation in 3D modeling of plasma-material interfaces. Scientific Awards: 2020 Thomas and Suzanne Werner Chair Professorship 2018 UW Madison Teaching Academy Fellow 2017 ITER Science Fellowship & Vilas Mid-Career Award 2015 DOE Early Career Award & NSF CAREER Award 2011 Torkil Jensen Award (General Atomics) 2007 Günther-Leibfried-Preis (Jülich) Professor Schmitz directs multiple DOE/NSF-funded research programs including his UW Madison laboratory and AWAKE project contributions at CERN. He mentors graduate students through NE 890/990 thesis research courses and has developed nationally recognized K-12 outreach including the "Plasma Show" for elementary schools and "Plasma Academy" for high-school educators developing AP Physics curriculum modules. His leadership extends to university governance through the Kaufman seminar on academic leadership. His research group operates helicon plasma test stands and computational facilities for EMC3-EIRENE simulations, with current efforts focused on high-density plasma sources for accelerators and resilient divertor solutions for stellarators. The group maintains strong international collaborations with ITER, CERN, and major fusion facilities worldwide.
Dorte Hammershøi is a Professor in the Department of Electronic Systems at The Technical Faculty of IT and Design, Aalborg University, Denmark. Her research focuses on acoustics, sound engineering, and hearing science with significant contributions to human hearing, ear canal acoustics, and audio technology applications. Her research interests include: Temporary Threshold Shift and frequency resolution in human hearing Ear canal acoustics and sound pressure level measurement Distortion Product Otoacoustic Emission (DPOAE) analysis Impulse response and acoustic impedance studies Hearing aid technology and rehabilitation methodologies Virtual reality audio interfaces and accessibility applications Professor Hammershøi's recent publications demonstrate a strong clinical-engineering interdisciplinary approach, bridging theoretical acoustics with practical hearing rehabilitation applications. Her work on hearing aid fitting methodologies, occupational noise exposure effects, and virtual reality audio interfaces shows consistent innovation in translating engineering principles to clinical practice. The research shows particular attention to individualized hearing solutions and accessibility technologies. Her scientific contributions have been recognized with: Dansk Lydpris 2020 (awarded November 17, 2021) Ambassadør for Aalborg (awarded September 15, 2004) Professor Hammershøi has supervised 5 PhD students and led numerous research projects including the ongoing "Audio Only VR for Blind Gamers" project (2024-2028) funded by the Independent Research Foundation of Denmark, and the completed "BEAR: Better Hearing Rehabilitation" project (2016-2022). Her research has attracted significant media attention with 110 press/media appearances discussing hearing damage prevention, tinnitus, and public health implications of noise exposure. She maintains active professional engagement through committee memberships (46 documented activities), international collaborations, and contributions to clinical practice guidelines. Her work continues to influence both academic research and practical applications in hearing science and audio engineering.
Giuseppe Rizzo is a Full Professor at the Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome. His academic career focuses on Maternal Fetal Medicine, with expertise in ultrasound applications, fetal growth restriction, preeclampsia, and congenital anomalies. Research Interests : Delivery optimization, prematurity prediction, ultrasound diagnostics, and placental anomalies. Recent Publications : Over 15 high-impact studies in 2024-2025 on topics like umbilical cord abnormalities, cerebroplacental ratios, and gestational diabetes complications. Clinical Expertise : Prenatal counseling, Doppler ultrasound, and labor management protocols. Collaborations : Active in multicenter trials across Italy and Europe, with a focus on fetal neurosonology and high-fidelity obstetric simulation.
Professor Hanadi Sleiman is a renowned academic in the Department of Chemistry at McGill University, specializing in DNA-based nanomaterials and their applications in drug delivery and supramolecular chemistry. She holds leadership roles, including Director of the NSERC CREATE training program in Nucleic Acids and President of the International DNA Nanotechnology Society (ISNSCE). Her research focuses on engineering DNA nanostructures for targeted therapies, such as cancer treatments, and advancing materials chemistry through DNA-functionalized systems. Education: Ph.D. in Chemistry, Stanford University (1990) Postdoctoral Fellow, University of Louis Pasteur (1993) Research Interests: Professor Sleiman’s work combines synthetic chemistry with DNA self-assembly to create programmable materials. Her lab designs DNA cages for drug encapsulation, explores DNA-minimal approaches to scalable materials, and integrates DNA with nanoparticles, polymers, and metals for biomedical applications. Key areas include cancer therapy, biosensors, and enzyme mimics. Awards & Honors: Fellow of the Royal Society of Canada (2017) Killam Research Fellowship (2018) R. U. Lemieux Award in Organic Chemistry (2018) William Dawson Scholar Award (2004–2012) Grants & Collaborations: She directs the NSERC CREATE program and collaborates with institutions like the Quebec Centre for Advanced Materials (QCAM) and the McGill Centre for Structural Biology (CRBS). Her training initiatives emphasize nucleic acid therapeutics and diagnostics. Labs & Teams: Her Sleiman Group at McGill develops innovative DNA architectures in the Otto Maass laboratory, with a focus on translational research for clinical applications.
Jerome Engel, M.D., Ph.D. is a Professor at the Jane and Terry Semel Institute for Neuroscience and Human Behavior , University of California, Los Angeles (UCLA). He serves as Director of the Epilepsy Telemetry Unit within the Seizure Disorder Center and is a member of the Brain Research Institute and the Neuroscience GPB Home Area. His work spans neurology, psychiatry, and biomedical research. Research Focus: Epilepsy, epileptogenesis, high-frequency oscillations (HFOs), neuroimaging, surgical interventions, and biomarker development. Key Contributions: Pioneering studies on fast ripples as biomarkers, network-based surgical outcome prediction, and advanced HFO detection algorithms. Publications (15 most recent) address topics such as kainic acid models of epileptogenesis, thalamic sleep spindles in pediatric epilepsy, self-supervised HFO analysis, and graph theoretical measures for surgical planning. His work frequently employs medRxiv and Epilepsia as platforms for translational findings. Contact: engel@ucla.edu
Dr. James Ashton-Miller is a prominent faculty member in the Department of Mechanical Engineering at the University of Michigan, where he directs the Biomechanics Research Laboratory. He serves as a Center Member of the University of Michigan Injury Prevention Center and maintains affiliations with the Institute of Gerontology. His interdisciplinary work bridges engineering principles with medical applications, focusing on injury prevention across sports medicine, obstetrics, and geriatrics. Dr. Ashton-Miller's educational background includes: PhD from the University of Oslo, Oslo, Norway (1978-1983) MSME from M.I.T., Cambridge, MA, U.S.A (1972-1974) B.SC. (Hons) from the University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, England (1967-1972) His research focuses on the biomechanics of injury prevention across multiple critical domains. In sports medicine, he has demonstrated that some ACL injuries are overuse injuries resulting from too many sub-maximal loading cycles that prevent healing of collagen damage. In women's health, his work on childbirth injuries addresses conditions that affect more women than breast cancer. His research on fall-related injuries in older adults reveals the dual threat of physical and cognitive factors. He also investigates sciatica, disc degeneration, and develops new medical devices for screening, diagnosis and treatment. Dr. Ashton-Miller's recent publications show a strong trend toward developing practical clinical applications from fundamental biomechanical research, with emphasis on advanced imaging methods, wearable sensors, and computational modeling for pelvic floor function assessment. His work consistently aims to translate engineering insights into clinical solutions for injury prevention. His research insights have earned him numerous national and international research awards, though specific awards aren't detailed in the available information. His work involves close collaboration with clinicians and surgeons who meet weekly to discuss progress and next steps. Dr. Ashton-Miller is deeply committed to mentoring, working with NIH K-series fellows along with 1-2 post-doctoral fellows, 3-5 PhD students, 2-4 M.S. students, 4-5 undergraduate students, and 2-4 young clinicians. His research is generously supported by the National Institutes of Health, National Science Foundation, National Basketball Association, Fortune 500 companies, and startup companies including Procter & Gamble and Hologic, Inc. He directs the Biomechanics Research Laboratory and co-leads the Pelvic Floor Research Group, where his teams develop new medical devices to improve screening, diagnosis, and treatment of various biomechanical conditions. These laboratories maintain strong clinical connections, ensuring research remains grounded in real-world medical challenges.
Prof. Dr. Eling de Bruin is a Lecturer at the Department of Health Sciences and Technology (D-HEST) at ETH Zurich. His research focuses on developing and evaluating exergame-based interventions targeting neurocognitive disorders, motor-cognitive training for aging populations, and stroke rehabilitation. He leads studies on personalized exergame protocols (e.g., PEMOCS framework) and their impact on cognitive function, gait recovery, and fall prevention. His work integrates wearable sensor technology, biofeedback systems, and clinical assessment tools to improve outcomes for chronic conditions like stroke, diabetes, and sarcopenia. Key areas include exergame design, hybrid training modalities, and biomarker validation (e.g., heart rate variability for neurocognitive screening). His research also explores sports biomechanics in youth athletes and injury prevention strategies for alpine skiers. Collaborative projects involve interdisciplinary teams from rehabilitation medicine, biomedical engineering, and computer science to create user-centered exergame solutions. Current initiatives emphasize home-based interventions and tele-rehabilitation to enhance accessibility for older adults and long-term care residents. Methodological contributions include validation of motor-cognitive assessment systems using virtual reality and inertial measurement units.
Colin Cooper is a Professor of Cancer Genetics at the Norwich Medical School, University of East Anglia. He is also a member of the Metabolic Health and Cancer Studies research groups. His work focuses on genomic evolution, tumor microbiome dynamics, and biomarker development for prostate cancer and musculoskeletal health. Cooper’s recent research explores the interplay between cancer genetics and microbial communities, emphasizing their role in prognosis and treatment outcomes. He investigates clonal evolution in tumors, mutational signatures, and non-invasive diagnostic tools like urinary extracellular vesicles. His collaborations span genomics, microbiology, and clinical applications. 2025: Causes of evolutionary divergence in prostate cancer (Genomics, Precision Medicine) 2024: Applications of urinary extracellular vesicles... (Biomarker Development, Liquid Biopsy) 2023: Caution regarding pan-cancer microbial structure (Methodological Considerations, Microbiome Analysis) In 2022, Cooper received the European Urology Oncology SoMe Award for his contributions. His work is frequently cited and has been featured in media outlets globally, highlighting his impact on cancer and aging research.
Jana Kainerstorfer is a Professor of Biomedical Engineering at Carnegie Mellon University (CMU), with courtesy appointments in the Neuroscience Institute and Electrical & Computer Engineering. She serves as Associate Department Head for Faculty and Graduate Affairs within the College of Engineering. Her research focuses on developing non-invasive optical imaging methods for disease detection and treatment monitoring, particularly in diffuse optical imaging. Key areas include cerebral hemodynamic monitoring in traumatic brain injury and handheld devices for breast cancer imaging. Dr. Kainerstorfer holds senior membership in the Optical Society of America and has received prestigious awards such as the NIH Trailblazer Award and AHA Scientist Development Grant. She leads the Biophotonics Lab, which bridges engineering and clinical applications, emphasizing translational research. Education: PhD from University of Vienna/NIH (2010), Postdoc at Tufts University Research Interests Her work revolves around biomedical optics , neurophotonics , and medical device innovation . Current projects include: Non-invasive cerebral hemodynamic monitoring Transabdominal fetal pulse oximetry Optical imaging in extreme environments (e.g., freediving physiology) Her lab develops tools like wearable NIRS for marine mammals and self-calibrating pulse oximetry algorithms. Research spans clinical translation and physiological mechanism discovery , with emphasis on microvascular imaging. Awards & Recognition NIH Trailblazer Award (2020) AHA Scientist Development Grant SPIE Fellow (2022) George Tallman Ladd Award (CMU) Lab & Collaborations The Biophotonics Lab collaborates with neurosurgery, oncology, and marine biology teams. Projects address clinical needs in neurocritical care and fetal monitoring, leveraging optical technologies for real-time diagnostics. Ongoing work includes: Optical assessment of cerebral metabolic rates Non-invasive intracranial pressure estimation Multi-modal EEG-NIRS fusion for neural source localization
Jennifer Dy is a Distinguished Professor at Northeastern University with joint appointments in Electrical and Computer Engineering and Khoury College of Computer Sciences. As Director of AI Faculty at the Institute for Experiential AI, she leads research in machine learning, computer vision, and explainable AI. Her work spans biomedical applications (COPD phenotyping, neuroimaging) and fundamental algorithms (active learning, continual learning). She holds a PhD from Purdue University and is an AAAI Fellow. Research Focus: Dy develops methodologies for robust and interpretable machine learning, including techniques for model stability in continual learning, dependency-aware active learning, and axiomatic explanation frameworks. Her applied research advances diagnostic tools using Raman spectroscopy, CT imaging, and multi-omics biomarker discovery. Awards: Recognized with the NSF CAREER Award, Faculty Research Team Award, and AAAI Fellowship for contributions to unsupervised learning and medical AI. Publication Trends: Recent articles demonstrate strong cross-disciplinary integration, combining theoretical advances in explainability/robustness with applications in healthcare, wireless systems, and particle physics. Methodological themes include optimal transport theory, probabilistic modeling, and transformer architectures.
Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Monash University and Alfred Health in Melbourne, Australia. She is an NHMRC Leadership Fellow (2021–2025) and a Chief Investigator for the NHMRC Centre of Research Excellence in Pulmonary Fibrosis and the NHMRC Centre of Research Excellence in Treatable Traits. Her research focuses on supportive therapies for chronic respiratory diseases, particularly COPD and pulmonary fibrosis, with a strong emphasis on pulmonary rehabilitation, telerehabilitation, and ambulatory oxygen therapy. Her research interests include: Respiratory physiotherapy Pulmonary rehabilitation (home-based and low-cost models) Access to care for chronic lung disease Telerehabilitation and digital health Symptom management in interstitial lung disease Exercise training and physical activity promotion Her recent publications focus on symptom management, digital self-management tools, treatable traits models, and clinical trials in pulmonary fibrosis and COPD. The body of work reflects a strong trend toward patient-centered, accessible, and evidence-based interventions that improve quality of life and clinical outcomes in chronic respiratory conditions. Her major scientific awards include: Society Medal, Thoracic Society of Australia and New Zealand (2021) European Respiratory Society Gold Medal for Allied Health Professionals (2022) NHMRC Investigator Fellow (Leadership 1) (2021) Fellow, Thoracic Society of Australia and New Zealand (2019) American Thoracic Society Pulmonary Rehabilitation Assembly Award (2016) Anne Holland supervises PhD students and is actively involved in advising and grant leadership. She is the Primary Chief Investigator on major trials such as the PERFORM trial and the TAPPET trial, and she leads a multinational ambulatory oxygen trial for fibrotic lung disease. Her work is supported by NHMRC and international collaborations. She is also President of the Thoracic Society of Australia and New Zealand, reflecting her leadership in the field. Anne leads the Holland Respiratory Care Research Group at Monash, which focuses on innovative models of care delivery, validation of remote monitoring tools, and improving patient self-management in chronic lung disease. The team collaborates widely across Australia and internationally, particularly in trials involving pulmonary rehabilitation and treatable traits.
Prof. Dr. med. Franz Lennard Ricklefs is a Senior Physician and Head of the Working Group at the Department of Neurosurgery, University of Hamburg Faculty of Medicine. He is a Medical Specialist in Neurosurgery with cross-disciplinary expertise in neuro-oncology, molecular pathology, and extracellular vesicle research. Affiliations: University Medical Center Hamburg-Eppendorf (UKE), European Liquid Biopsy Society (ELBS), International Consortium on Meningiomas (ICOM) Research Interests: His work focuses on neurosurgical oncology, particularly glioblastoma and meningioma pathobiology. He investigates DNA methylation patterns, extracellular vesicle biomarkers, and liquid biopsy implementation in clinical neuro-oncology. Additional interests include surgical outcomes for epilepsy and aneurysm management. Article Trends: Over the last decade, Dr. Ricklefs has published extensively on: Extracellular vesicle applications as liquid biopsy markers DNA methylation subclasses for glioblastoma and meningioma Multicenter surgical outcome benchmarking Immune evasion mechanisms in neuro-oncology Technological innovations in neurosurgical visualization Molecular characterization of rare CNS tumors Professional Contributions: He co-authored the MISEV2023 guidelines for extracellular vesicle studies and participates in international consensus reviews for meningioma classification. His collaborations span institutions across Europe and North America.
Gianmarco Pinton is an Associate Professor in the Department of Biomedical Engineering at the University of North Carolina at Chapel Hill. His research focuses on nonlinear ultrasound and mechanical wave propagation, with applications to medical imaging and therapy. He specializes in traumatic brain injury, shear shock waves, and ultrasound therapy. Ph.D., M.S., and B.S.E. in Biomedical Engineering/Physics from Duke University His lab develops physics and simulation tools for nonlinear wave propagation, aiming to create advanced diagnostic ultrasound methods. Key areas include traumatic brain injury, transcranial imaging, and therapeutic ultrasound. His recent work explores super-resolution imaging, brain motor circuits, and Alzheimer's disease vascular mapping using ultrasound. Article trends highlight innovations in transcranial ultrasound, super-resolution techniques, lung imaging, and neuromodulation. His publications address image degradation, contrast agents, and shear wave dynamics in neurological contexts.
Dr. Ava Hedayatipour is an Assistant Professor of Electrical Engineering at California State University at Long Beach (CSULB), where she joined in Fall 2020. She holds a Ph.D. from the University of Tennessee, Knoxville (2020), and degrees from Iran University of Science and Technology (B.S., 2012) and Shahid Rajaee Teacher Training University (M.S., 2015). Her research focuses on analog/mixed-signal circuit design, bio-implantable devices, low-power systems, and hardware security. Notable contributions include a first-of-its-kind integrated secure multimodal sensor and a flexible paper electrode for remote electrochemical experiments. Education: Ph.D., Electrical Engineering, University of Tennessee, Knoxville, 2020 M.S., Electrical Engineering, Shahid Rajaee Teacher Training University, Iran, 2015 B.S., Electrical Engineering, Iran University of Science and Technology, 2012 Research Interests: Analog and mixed-signal circuit design Biomedical devices and lab-on-chip applications Low-power, low-noise microelectronics Hardware security for IoT and biomedical sensors Flexible electrodes for wearable systems Awards: University of Tennessee Fellowship Award (2019) Outstanding Teaching Assistant Award (2018) BEST PAPER AWARD at IEEE DCAS 2025 2nd Place Winner at IEEE BIOCAS 2023 Innovation Challenge Advising & Grants: Lead CSULB LEAP program project on medical imaging braces Funded NSF project on chaotic analog security (2018–present) Collaborated with industry partners like Applied Medical and Synaptics Labs & Teams: Next Generation Wearable Lab at CSULB Focus on sensor design, hardware security, and biomedical applications
